Intellia Therapeutics, Inc.

By person

29 insiders · 296 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

FORMELA JEAN FRANCOIS

Director

—

$155.43M (46)

−$155.43M

580,667

0.4144%

$7.55M

−75.9%

LEONARD JOHN M

President and CEO

—

$54.97M (59) scheduled

−$54.97M

1,205,479

0.8603%

$15.67M

+129.3%

Novartis Institutes for BioMedical Research, Inc. entity

10% owner

—

$27.87M (1)

−$27.87M

4,129,903

2.95%

$53.69M

−25.9%

Sepp-Lorenzino Laura

EVP, Chief Scientific Officer

—

$19.26M (24) scheduled

−$19.26M

77,388

0.0552%

$1.01M

+1,648%

Caribou Biosciences, Inc. entity

10% owner

—

$14.75M (2)

−$14.75M

3,994,355

2.85%

$51.93M

−28.6%

Rivera Jose E

EVP, General Counsel

—

$9.82M (47) scheduled

−$9.82M

686,808

0.4901%

$8.93M

+29.4%

Goddard Glenn

EVP, Chief Financial Officer

—

$8.79M (16) scheduled

−$8.79M

69,213

0.0494%

$899.77K

—

Bermingham Nessan

President & CEO

—

$7.00M (5)

−$7.00M

458,250

0.3270%

$5.96M

−41.7%

KARSEN PERRY A

Director

—

$4.75M (3) scheduled

−$4.75M

5,000

0.0036%

$65.00K

—

Atlas Venture Fund IX, L.P. entity

10% owner

—

$2.44M (3)

−$2.44M

3,579,788

2.55%

$46.54M

−19.2%

Lebwohl David

EVP, Chief Medical Officer

—

$2.37M (21) scheduled

−$2.37M

131,192

0.0936%

$1.71M

+2,466%

Crowley John F

Director

—

$1.60M (6) scheduled

−$1.60M

11,716

0.0084%

$152.31K

—

Cohen Fred E

Director

$1.40M (1)

—

+$1.40M

216,653

0.1546%

$2.82M

—

CHASE WILLIAM J

Director

$1.00M (1)

—

+$1.00M

143,893

0.1027%

$1.87M

+2,016%

Clark Eliana

EVP, Chief Technical Officer

—

$690.37K (15)

−$690.37K

93,864

0.0670%

$1.22M

+849.3%

DORSA CAROLINE

Director

—

$616.40K (3) scheduled

−$616.40K

12,701

0.0091%

$165.11K

—

BASTA JAMES

EVP, General Counsel

—

$499.69K (8)

−$499.69K

156,794

0.1119%

$2.04M

+1,408%

Dulac Edward J III

EVP, Chief Financial Officer

—

$338.80K (4)

−$338.80K

148,175

0.1057%

$1.93M

—

Atlas Venture Associates IX, L.P. entity

10% owner

—

$293.84K (2)

−$293.84K

3,729,788

2.66%

$48.49M

−0.6%

Hicks Derek

EVP, Chief Business Officer

—

$260.84K (3)

−$260.84K

59,878

0.0427%

$778.41K

—

Dube Michael P

VP, Chief Accounting Officer

—

$184.23K (6)

−$184.23K

66,886

0.0477%

$869.52K

+114.2%

Bhanji Muna

Director

—

$95.82K (5) scheduled

−$95.82K

36,403

0.0260%

$473.24K

—

Schultes Birgit C

EVP, Chief Scientific Officer

—

$78.90K (2)

−$78.90K

137,733

0.0983%

$1.79M

+98.3%

SCHIERMEIER ANDREW

EVP, Chief Operating Officer

$117.88K (2)

$76.92K (1)

+$40.96K

16,656

0.0119%

$216.53K

+292.7%

Verwiel Frank

Director

—

$37.63K (1) scheduled

−$37.63K

35,148

0.0251%

$456.92K

—

GOODMAN JESSE

Director

—

$29.07K (2) scheduled

−$29.07K

33,559

0.0239%

$436.27K

—

Keresty Georgia

Director

—

41,083

0.0293%

$534.08K

—

Goff Brian

Director

—

32,609

0.0233%

$423.92K

—

Bell Graeme

EVP, Chief Financial Officer

—

21,400

0.0153%

$278.20K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

LEONARD JOHN M

12 Dec 2025

President and CEO

Exercised, kept

8,557

$6.83

$58.44K

Lebwohl David

24 Sep 2021

EVP, Chief Medical Officer

Exercised, kept

7,923

$12.62

$99.99K

LEONARD JOHN M

13 Apr 2021

President and CEO

Exercised, kept

15,937

$13.88

$221.21K

LEONARD JOHN M

13 Apr 2021

President and CEO

Exercised, kept

10,000

$6.83

$68.30K

Cohen Fred E

20 Jan 2021

Director

Exercised, kept

20,000

$13.78

$275.60K

SCHIERMEIER ANDREW

30 Dec 2020

EVP, Chief Operating Officer

Exercised, kept

1,500

$13.48

$20.22K

Showing 250 of 296 transactions. The figures above use every one of them.

Intellia Therapeutics, Inc.

By person

Individual transactions

What was left out